Crown Bioscience Inc.
Crown Bioscience to Showcase Scientific Expertise at Cambridge UK Symposium: Preclinical Evaluation of Novel Immunotherapies
SAN DIEGO, March 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces it will host its annual Cambridge UK symposium on Thursday, March 15th at The Cambridge Building, Babraham Research Campus.
The scientific symposium, entitled "Perspectives on Oncology Drug Discovery; Immuno-Oncology and the Next Generation", will bring together some of the most influential names in preclinical oncology drug discovery. Distinguished speakers from various multinational pharmaceutical and European biotech companies will present data describing how their latest research efforts provide innovative, unique solutions to advance immunotherapeutics and preclinical pharmacology evaluation.
"I look forward to welcoming the scientific community to our 4th annual Cambridge UK Symposium", said Dr. Sebastian Dempe, CrownBio's Executive Director UK and European business unit. "Immuno-oncology and its preclinical modeling has become a tremendously important focus in cancer research. This year's symposium promises to provide an excellent opportunity for networking and scientific discussions around the latest advances in immuno-oncology research."
Register to attend the symposium here, http://bit.ly/CrownBio_Cambridge18
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
Crown Bioscience Inc.
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
BrandSafway22.2.2019 20:01:18 | Pressemeddelelse
BrandSafway™ Announces Acquisition of Century Elevators
Magna International Inc.22.2.2019 11:01:37 | Pressemeddelelse
Magna Announces Fourth Quarter and 2018 Results and Raises Quarterly Cash Dividend by 11%
IMImobile22.2.2019 10:38:35 | Pressemeddelelse
IMImobile announces integration of WhatsApp Business solution into its enterprise cloud communications platform IMIconnect
Cloudstreet22.2.2019 09:02:06 | Pressemeddelelse
Nordic Innovators Cloudstreet and Domos Partner to Deliver an End-to-End, Application-Aware 5G Experience to the Home
PubMatic, Inc.21.2.2019 15:01:38 | Pressemeddelelse
PubMatic Launches OpenBid, Bringing Full Strength of Programmatic Monetization to the Mobile App Environment
IMImobile21.2.2019 11:10:32 | Pressemeddelelse
IMImobile releases unified RCS Messaging API to accelerate RCS adoption for enterprise customer communications
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum